<p>Clinical-Decision Criteria to Identify Recurrent Diabetic Macular Edema Patients Suitable for Fluocinolone Acetonide Implant Therapy (ILUVIEN<sup>®</sup>) and Follow-Up Considerations/Recommendations</p>-Reference-Cited by-同舟云学术

Clinical-Decision Criteria to Identify Recurrent Diabetic Macular Edema Patients Suitable for Fluocinolone Acetonide Implant Therapy (ILUVIEN^®) and Follow-Up Considerations/Recommendations

Published:2020-07 Issue: Volume:Volume 14 Page:2091-2107
ISSN:1177-5483
Container-title:Clinical Ophthalmology
language:en
Short-container-title:OPTH

Author:

Adán Alfredo^ORCID,Cabrera Francisco^ORCID,Figueroa Marta S,Cervera Enrique,Ascaso Francisco J,Udaondo Patricia^ORCID,Abraldes Maximino^ORCID,Reyes Miguel Ángel^ORCID,Pazos Marta,Pessoa Bernardete^ORCID,Armadá Félix^ORCID

Publisher

Informa UK Limited

Subject

Ophthalmology

Reference96 articles.

1. Guidelines for the Management of Diabetic Macular Edema by the European Society of Retina Specialists (EURETINA)

2. Ranibizumab for Diabetic Macular Edema

3. Expanded 2-Year Follow-up of Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema

4. Long-term Outcomes of Ranibizumab Therapy for Diabetic Macular Edema: The 36-Month Results from Two Phase III Trials

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Evidence of the Long-Term Effectiveness of 0.2 μg/Day Fluocinolone Acetonide Implant in Persistent and Recurrent Diabetic Macular Edema – A Single Center Study;Clinical Ophthalmology;2024-04

2. DEXTENZA versus Topical Steroid or Antihistamine Therapy for Treatment of Allergic Conjunctivitis;Clinical Ophthalmology;2024-02

3. ILUVIEN^® in diabetic macular edema that persists or recurs despite treatment: Results from the Retina.pt^® RIVER audit;European Journal of Ophthalmology;2023-11-28

4. Ocular hypertension and intravitreal steroids injections, update in 2023. French guidelines of the French glaucoma society and the French ophthalmology society;Journal Français d'Ophtalmologie;2023-10

5. Hypertonie oculaire et injection intravitréenne d’implant de corticoïde, état de l’art en 2023. Recommandations françaises SFG/SFO [version française];Journal Français d'Ophtalmologie;2023-09